Halozyme Therapeutics
HALO
#2424
Rank
ยฃ5.50 B
Marketcap
ยฃ46.81
Share price
1.26%
Change (1 day)
21.65%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: ยฃ5.50 Billion

As of December 2025 Halozyme Therapeutics has a market cap of ยฃ5.50 Billion. This makes Halozyme Therapeutics the world's 2424th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ5.50 B12.81%
2024ยฃ4.87 B27.33%
2023ยฃ3.83 B-39.74%
2022ยฃ6.35 B51.64%
2021ยฃ4.19 B-0.99%
2020ยฃ4.23 B129.15%
2019ยฃ1.84 B10.82%
2018ยฃ1.66 B-21.84%
2017ยฃ2.13 B105.82%
2016ยฃ1.03 B-30.81%
2015ยฃ1.49 B92.32%
2014ยฃ0.77 B-25.13%
2013ยฃ1.04 B122.44%
2012ยฃ0.46 B-26.25%
2011ยฃ0.63 B22.95%
2010ยฃ0.51 B55.16%
2009ยฃ0.33 B6.87%
2008ยฃ0.31 B11.61%
2007ยฃ0.27 B-1.3%
2006ยฃ0.28 B344.27%
2005ยฃ63.58 M12.77%
2004ยฃ56.38 M

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Halozyme Therapeutics was reported to be:

ยฃ5.43 Billion
by Nasdaq info icon info icon
ยฃ5.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
MannKind Corp
MNKD
ยฃ1.33 B-75.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ665.56 B 11,990.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ7.01 B 27.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ109.52 B 1,889.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ88.01 B 1,498.91%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
ยฃ371.81 B 6,654.25%๐Ÿ‡บ๐Ÿ‡ธ USA